Cargando…

MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma

BACKGROUND: Deregulation of microRNA (miRNA) transcript levels has been observed in many types of tumors including osteosarcoma. Molecular pathways regulated by differentially expressed miRNAs may contribute to the heterogeneous tumor behaviors observed in naturally occurring cancers. Thus, tumor-as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarver, Aaron L, Thayanithy, Venugopal, Scott, Milcah C, Cleton-Jansen, Anne-Marie, Hogendoorn, Pancras CW, Modiano, Jaime F, Subramanian, Subbaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566973/ https://www.ncbi.nlm.nih.gov/pubmed/23311495 http://dx.doi.org/10.1186/1750-1172-8-7

Ejemplares similares

Imprinting defects at human 14q32 locus alters gene expression and is associated with the pathobiology of osteosarcoma
por: Shu, Jingmin, et al.
Publicado: (2016)

Combinatorial Treatment of DNA and Chromatin-Modifying Drugs Cause Cell Death in Human and Canine Osteosarcoma Cell Lines
por: Thayanithy, Venugopal, et al.
Publicado: (2012)

Osteosarcoma Models: From Cell Lines to Zebrafish
por: Mohseny, Alexander B., et al.
Publicado: (2012)

Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior
por: Scott, Milcah C., et al.
Publicado: (2016)

Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach
por: Varshney, Jyotika, et al.
Publicado: (2016)

Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
por: Kuijjer, Marieke L, et al.
Publicado: (2014)

Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo
por: Meijer, Danielle, et al.
Publicado: (2011)

Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
por: Baranski, Zuzanna, et al.
Publicado: (2015)

mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
por: Kuijjer, Marieke L, et al.
Publicado: (2011)

IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
por: Kuijjer, Marieke L, et al.
Publicado: (2013)

MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation
por: Baranski, Zuzanna, et al.
Publicado: (2015)

Mesenchymal stem cell transformation and sarcoma genesis
por: Xiao, Wei, et al.
Publicado: (2013)

Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
por: Schrage, Yvonne M, et al.
Publicado: (2009)

A transwell assay that excludes exosomes for assessment of tunneling nanotube-mediated intercellular communication
por: Thayanithy, Venugopal, et al.
Publicado: (2017)

Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors
por: Cannon, Claire M, et al.
Publicado: (2013)

Competing endogenous RNA database
por: Sarver, Aaron L, et al.
Publicado: (2012)

Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population
por: Martin-Guerrero, Idoia, et al.
Publicado: (2018)

Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
por: Kresse, Stine H., et al.
Publicado: (2012)

Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm
por: Bovée, Judith VMG, et al.
Publicado: (2019)

Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment
por: van Maldegem, Annemiek M, et al.
Publicado: (2012)

OMCD: OncomiR Cancer Database
por: Sarver, Aaron L., et al.
Publicado: (2018)

Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture
por: Buddingh, Emilie P, et al.
Publicado: (2015)

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
por: Cleton-Jansen, A. M., et al.
Publicado: (1995)

Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review
por: Makielski, Kelly M., et al.
Publicado: (2019)

MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32
por: Kelly, Andrew D, et al.
Publicado: (2013)

A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes
por: Romeo, Salvatore, et al.
Publicado: (2009)

Arginase Treatment Prevents the Recovery of Canine Lymphoma and Osteosarcoma Cells Resistant to the Toxic Effects of Prolonged Arginine Deprivation
por: Wells, James W., et al.
Publicado: (2013)

The clinical use of biomarkers as prognostic factors in Ewing sarcoma
por: van Maldegem, Annmeik M, et al.
Publicado: (2012)

Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells
por: Desir, Snider, et al.
Publicado: (2016)

Formation of a large, complex domain of histone hyperacetylation at human 14q32.1 requires the serpin locus control region
por: Baxter, Euan W., et al.
Publicado: (2005)

MicroRNAs Clustered within the 14q32 Locus Are Associated with Endothelial Damage and Microparticle Secretion in Bicuspid Aortic Valve Disease
por: Martínez-Micaelo, Neus, et al.
Publicado: (2017)

HHIPL1, a Gene at the 14q32 Coronary Artery Disease Locus, Positively Regulates Hedgehog Signaling and Promotes Atherosclerosis
por: Aravani, Dimitra, et al.
Publicado: (2019)

Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors
por: Chen, Yiyuan, et al.
Publicado: (2020)

Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling Pathway
por: Nord, Karolin H., et al.
Publicado: (2013)

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma
por: Gattolliat, C-H, et al.
Publicado: (2011)

The 14q32 maternally imprinted locus is a major source of longitudinally stable circulating microRNAs as measured by small RNA sequencing
por: Valbuena, Gabriel N., et al.
Publicado: (2019)

An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets
por: Hill, Katherine E., et al.
Publicado: (2017)

Genetic regulatory and biological implications of the 10q24.32 schizophrenia risk locus
por: Wang, Junyang, et al.
Publicado: (2022)

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup
por: McTiernan, Anne, et al.
Publicado: (2012)

14q32-encoded microRNAs mediate an oligometastatic phenotype
por: Uppal, Abhineet, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n52cm1vs7dfc04ko53c81gpass